Oncology
2 drugs are in development for Glioblastoma.
- Companies
- 2
- Clinical trials
- 79
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Glioblastoma pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Preclinical(1)
| Drug | Company |
|---|---|
| BF-223 | Bullfrog AI Holdings Inc. (BFRG) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| mn-166 | MEDICINOVA INC (MNOV) |
About this indication
Glioblastoma context
Oncology·MeSH: Glioblastoma (D005909)
Also known as: Astrocytomas, Grade IV, Glioblastomas, Grade IV Astrocytoma
Narrower concepts tracked separately: Glioblastoma Multiforme (GBM), Glioblastoma Multiforme
Prevalence
3.2 / 100K
Incidence
3.2 / 100K/yr
Frequently asked questions
How many drugs are in development for Glioblastoma?
BioSniper tracks 2 drugs in development for Glioblastoma across 2 companies.
How many clinical trials target Glioblastoma?
There are 79 clinical trials targeting Glioblastoma tracked by BioSniper.
What is the prevalence of Glioblastoma?
The estimated prevalence of Glioblastoma is approximately 3.2 per 100,000 population.